{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:21:39Z","timestamp":1779294099867,"version":"3.51.4"},"update-to":[{"DOI":"10.1371\/journal.pntd.0006039","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000}}],"reference-count":79,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["2G12MD007592"],"award-info":[{"award-number":["2G12MD007592"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R25GM069621"],"award-info":[{"award-number":["R25GM069621"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Shefa Fund"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006039","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T17:29:54Z","timestamp":1508952594000},"page":"e0006039","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["An \u03b1-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major"],"prefix":"10.1371","volume":"11","author":[{"given":"Eva","family":"Iniguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel S.","family":"Schocker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishanthi","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Portillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba L.","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed S.","family":"Al-Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caresse L.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otacilio C.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvaro","family":"Acosta-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2443-8213","authenticated-orcid":true,"given":"Igor C.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa A.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"e0005739","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates","volume":"11","author":"F Bailey","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"e0004545","DOI":"10.1371\/journal.pntd.0004545","article-title":"Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa","volume":"10","author":"R Du","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3201\/eid2205.160042","article-title":"Cutaneous Leishmaniasis and Conflict in Syria","volume":"22","author":"WS Al-Salem","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"e3144","DOI":"10.1371\/journal.pntd.0003144","article-title":"Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of <italic>L<\/italic>. <italic>major<\/italic> cutaneous leishmaniasis","volume":"8","author":"A Fortin","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00436-011-2555-5","article-title":"<italic>Leishmania<\/italic> antimony resistance: what we know what we can learn from the field","volume":"109","author":"K Ait-Oudhia","year":"2011","journal-title":"Parasitol Res"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ije\/15.4.572","article-title":"Controlled field trials of a vaccine against New World cutaneous leishmaniasis","volume":"15","author":"CM Antunes","year":"1986","journal-title":"Int J Epidemiol"},{"issue":"9115","key":"ref8","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","article-title":"Randomised vaccine trial of single dose of killed <italic>Leishmania major<\/italic> plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran","volume":"351","author":"I Sharifi","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1586\/14760584.2014.894467","article-title":"Identifying vaccine targets for anti-leishmanial vaccine development","volume":"13","author":"S Sundar","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"Pt 2","key":"ref10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/bj2940305","article-title":"The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes","volume":"294","author":"MJ McConville","year":"1993","journal-title":"Biochem J"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"45R","DOI":"10.1093\/glycob\/11.4.45R","article-title":"Glycoconjugate structures of parasitic protozoa","volume":"11","author":"A Guha-Niyogi","year":"2001","journal-title":"Glycobiology"},{"key":"ref12","first-page":"193","article-title":"<italic>Leishmania<\/italic> lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?","volume":"4","author":"CL Forestier","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"issue":"31","key":"ref13","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.1039\/C5OB00563A","article-title":"<italic>Leishmania<\/italic> cell wall as a potent target for antiparasitic drugs. A focus on the glycoconjugates","volume":"13","author":"Y Cabezas","year":"2015","journal-title":"Org Biomol Chem"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.bbagen.2011.11.001","article-title":"Glycoconjugates in New World species of <italic>Leishmania<\/italic>: polymorphisms in lipophosphoglycan and glycoinositolphospholipids and interaction with hosts","volume":"1820","author":"RR de Assis","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 2","key":"ref15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/bj2950555","article-title":"Characterization of glycoinositol phospholipids in the amastigote stage of the protozoan parasite <italic>Leishmania major<\/italic>","volume":"295","author":"P Schneider","year":"1993","journal-title":"Biochem J"},{"issue":"16","key":"ref16","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1073\/pnas.88.16.7401","article-title":"Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys","volume":"88","author":"U Galili","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2\u20133","key":"ref17","first-page":"155","article-title":"Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody","volume":"15","author":"U Galili","year":"1993","journal-title":"Springer Semin Immunopathol"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0163-7827(96)00004-5","article-title":"Bacterial lipopolysaccharides\u2014themes and variations","volume":"35","author":"SG Wilkinson","year":"1996","journal-title":"Prog Lipid Res"},{"key":"ref19","first-page":"1","article-title":"The Natural Anti-Gal Antibody as Foe Turned Friend in Medicine","author":"U Galili","year":"2017"},{"issue":"6","key":"ref20","first-page":"1275","article-title":"Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance","volume":"21","author":"SR Milani","year":"1988","journal-title":"Braz J Med Biol Res"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.4049\/jimmunol.142.8.2828","article-title":"Immunogenic Gal alpha 1\u2014-3Gal carbohydrate epitopes are present on pathogenic American <italic>Trypanosoma<\/italic> and <italic>Leishmania<\/italic>","volume":"142","author":"JL Avila","year":"1989","journal-title":"J Immunol"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.4049\/jimmunol.146.7.2394","article-title":"Complement-mediated lysis of <italic>Trypanosoma cruzi<\/italic> trypomastigotes by human anti-alpha-galactosyl antibodies","volume":"146","author":"IC Almeida","year":"1991","journal-title":"J Immunol"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/JCM.29.10.2305-2312.1991","article-title":"Glycoinositol phospholipids from American <italic>Leishmania<\/italic> and <italic>Trypanosoma<\/italic> spp: partial characterization of the glycan cores and the human humoral immune response to them","volume":"29","author":"JL Avila","year":"1991","journal-title":"J Clin Microbiol"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4269\/ajtmh.1992.47.284","article-title":"Parasitic oligosaccharide residues recognized by patients with mucocutaneous and localized cutaneous leishmaniasis","volume":"47","author":"JL Avila","year":"1992","journal-title":"Am J Trop Med Hyg"},{"issue":"Pt 3","key":"ref25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1042\/bj3040793","article-title":"Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas&apos; disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of <italic>Trypanosoma cruzi<\/italic>","volume":"304","author":"IC Almeida","year":"1994","journal-title":"Biochem J"},{"issue":"14","key":"ref26","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1017\/S0031182014001607","article-title":"Detection of high levels of anti-alpha-galactosyl antibodies in sera of patients with Old World cutaneous leishmaniasis: a possible tool for diagnosis and biomarker for cure in an elimination setting","volume":"141","author":"WS Al-Salem","year":"2014","journal-title":"Parasitology"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.cell.2014.10.053","article-title":"Gut microbiota elicits a protective immune response against malaria transmission","volume":"159","author":"B Yilmaz","year":"2014","journal-title":"Cell"},{"issue":"9039","key":"ref28","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(96)04128-1","article-title":"Randomised trial of efficacy of benznidazole in treatment of early <italic>Trypanosoma cruzi<\/italic> infection","volume":"348","author":"AL de Andrade","year":"1996","journal-title":"Lancet"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1046\/j.1537-2995.1997.37897424410.x","article-title":"A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active <italic>Trypanosoma cruzi<\/italic> infection","volume":"37","author":"IC Almeida","year":"1997","journal-title":"Transfusion"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-3024.1991.tb00288.x","article-title":"Direct lysis of <italic>Trypanosoma cruzi<\/italic>: a novel effector mechanism of protection mediated by human anti-gal antibodies","volume":"13","author":"RT Gazzinelli","year":"1991","journal-title":"Parasite Immunol"},{"issue":"1","key":"ref31","first-page":"39","article-title":"Synthesis of Galalpha(1,3)Galbeta(1,4)GlcNAcalpha-, Galbeta(1,4)GlcNAcalpha- and GlcNAc-containing neoglycoproteins and their immunological evaluation in the context of Chagas disease","volume":"26","author":"NS Schocker","year":"2016","journal-title":"Glycobiology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fcimb.2017.00248","article-title":"Parasite Carbohydrate Vaccines","volume":"7","author":"JA Jaurigue","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"ref33","first-page":"556","article-title":"alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies","volume":"28","author":"AD Thall","year":"1996","journal-title":"Transplant Proc"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00007890-199601150-00004","article-title":"The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation","volume":"61","author":"RG Tearle","year":"1996","journal-title":"Transplantation"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0035-9203(85)90350-5","article-title":"Zoonotic cutaneous leishmaniasis in Saudi Arabia: the incrimination of Phlebotomus papatasi as the vector in the Al-Hassa oasis","volume":"79","author":"R Killick-Kendrick","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-6851(00)00270-X","article-title":"Episomal and stable expression of the luciferase reporter gene for quantifying <italic>Leishmania<\/italic> spp. infections in macrophages and in animal models","volume":"110","author":"G Roy","year":"2000","journal-title":"Mol Biochem Parasitol"},{"issue":"41","key":"ref37","doi-asserted-by":"crossref","DOI":"10.3791\/1980","article-title":"In vivo imaging of transgenic <italic>Leishmania<\/italic> parasites in a live host","author":"CJ Thalhofer","year":"2010","journal-title":"J Vis Exp"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/expr.2001.4656","article-title":"A lipophosphoglycan-independent method for isolation of infective <italic>Leishmania<\/italic> metacyclic promastigotes by density gradient centrifugation","volume":"99","author":"GF Spath","year":"2001","journal-title":"Exp Parasitol"},{"issue":"34","key":"ref39","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1039\/c3ob40887f","article-title":"Potential use of synthetic alpha-galactosyl-containing glycotopes of the parasite <italic>Trypanosoma cruzi<\/italic> as diagnostic antigens for Chagas disease","volume":"11","author":"RA Ashmus","year":"2013","journal-title":"Org Biomol Chem"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1371\/journal.pntd.0000419","article-title":"Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients","volume":"3","author":"T Duffy","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/JCM.42.11.5249-5255.2004","article-title":"Quantification of <italic>Leishmania infantum<\/italic> DNA by a real-time PCR assay with high sensitivity","volume":"42","author":"C Mary","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.exppara.2013.03.026","article-title":"An approach for interlaboratory comparison of conventional and real-time PCR assays for diagnosis of human leishmaniasis","volume":"134","author":"I Cruz","year":"2013","journal-title":"Exp Parasitol"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00007890-199601150-00004","article-title":"The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation","volume":"61","author":"RG Tearle","year":"1996","journal-title":"Transplantation"},{"issue":"Pt 7","key":"ref44","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1242\/jcs.113.7.1299","article-title":"Mucin-like molecules form a negatively charged coat that protects <italic>Trypanosoma cruzi<\/italic> trypomastigotes from killing by human anti-alpha-galactosyl antibodies","volume":"113","author":"VL Pereira-Chioccola","year":"2000","journal-title":"Journal of Cell Science"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0022-1759(89)90298-6","article-title":"Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates","volume":"120","author":"JM Peeters","year":"1989","journal-title":"J Immunol Methods"},{"issue":"14","key":"ref46","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1002\/chem.200400074","article-title":"The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein","volume":"10","author":"T Buskas","year":"2004","journal-title":"Chemistry"},{"issue":"4","key":"ref47","first-page":"377","article-title":"Effectiveness of leishmanization in the control of cutaneous leishmaniasis","volume":"76","author":"A Nadim","year":"1983","journal-title":"Bull Soc Pathol Exot Filiales"},{"issue":"1\u20132","key":"ref48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.vetimm.2011.02.007","article-title":"Immunological changes in canine peripheral blood leukocytes triggered by immunization with first or second generation vaccines against canine visceral leishmaniasis","volume":"141","author":"MS Araujo","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"issue":"52","key":"ref49","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"S Noazin","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/00034983.1985.11811917","article-title":"An experimental vaccine against American dermal leishmaniasis: experience in the State of Espirito Santo, Brazil","volume":"79","author":"W Mayrink","year":"1985","journal-title":"Ann Trop Med Parasitol"},{"issue":"10","key":"ref51","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.intimp.2011.05.008","article-title":"Vaccine candidates for leishmaniasis: a review","volume":"11","author":"R Nagill","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"R Kumar","year":"2014","journal-title":"Clin Transl Immunology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fimmu.2016.00151","article-title":"Cutaneous Leishmaniasis Vaccination: A Matter of Quality","volume":"7","author":"PM De Luca","year":"2016","journal-title":"Front Immunol"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/eji.200324736","article-title":"CpG DNA redirects class-switching towards &quot;Th1-like&quot; Ig isotype production via TLR9 and MyD88","volume":"34","author":"L Lin","year":"2004","journal-title":"Eur J Immunol"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.4049\/jimmunol.155.6.3102","article-title":"Role of the <italic>Leishmania<\/italic> surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis","volume":"155","author":"A Brittingham","year":"1995","journal-title":"J Immunol"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.4049\/jimmunol.134.4.2713","article-title":"Growth cycle-dependent generation of complement-resistant <italic>Leishmania<\/italic> promastigotes","volume":"134","author":"ED Franke","year":"1985","journal-title":"J Immunol"},{"issue":"9","key":"ref57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"P Scott","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00281-012-0350-8","article-title":"Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis","volume":"34","author":"L Soong","year":"2012","journal-title":"Semin Immunopathol"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1038\/s41598-017-06236-6","article-title":"Inflammatory monocytes regulate Th1 oriented immunity to CpG adjuvanted protein vaccines through production of IL-12","volume":"7","author":"S De Koker","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"ref60","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, <italic>Leishmania major<\/italic> stress-inducible protein 1, and <italic>Leishmania<\/italic> elongation initiation factor protects against leishmaniasis","volume":"70","author":"RN Coler","year":"2002","journal-title":"Infect Immun"},{"issue":"16","key":"ref61","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1073\/pnas.88.16.7011","article-title":"Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis","volume":"88","author":"FP Heinzel","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fimmu.2012.00032","article-title":"Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with <italic>L<\/italic>","volume":"3","author":"F Tacchini-Cottier","year":"2012","journal-title":"Front Immunol"},{"issue":"1\u20133","key":"ref63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12026-014-8536-x","article-title":"Eosinophils and mast cells in leishmaniasis","volume":"59","author":"NE Rodriguez","year":"2014","journal-title":"Immunol Res"},{"issue":"12","key":"ref64","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat-killed <italic>Leishmania<\/italic> antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against <italic>Leishmania major<\/italic> infection","volume":"195","author":"EG Rhee","year":"2002","journal-title":"J Exp Med"},{"issue":"4","key":"ref65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"RA Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"ref66","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1074-7613(00)00075-3","article-title":"Selective activation and expansion of high-affinity CD4+ T cells in resistant mice upon infection with <italic>Leishmania major<\/italic>","volume":"13","author":"L Malherbe","year":"2000","journal-title":"Immunity"},{"issue":"7","key":"ref67","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1134\/S0006297911070066","article-title":"Synthetic neoglycoconjugates of cell-surface phosphoglycans of <italic>Leishmania<\/italic> as potential anti-parasite carbohydrate vaccines","volume":"76","author":"AV Nikolaev","year":"2011","journal-title":"Biochemistry (Mosc)"},{"issue":"5","key":"ref68","first-page":"260","article-title":"Vaccination of BALB\/c mice with <italic>Leishmania donovani<\/italic> derived lipophosphoglycan does not conver cross-protection to <italic>L<\/italic>. <italic>major<\/italic> infections","volume":"80","author":"WK Tonui","year":"2003","journal-title":"East Afr Med J"},{"issue":"4","key":"ref69","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4102\/ojvr.v70i4.290","article-title":"<italic>Leishmania donovani<\/italic>-derived lipophosphoglycan plus BCG induces a Th1 type immune response but does not protect Syrian golden hamsters (<italic>Mesocricetus auratus<\/italic>) and BALB\/c mice against <italic>Leishmania donovani<\/italic>","volume":"70","author":"WK Tonui","year":"2003","journal-title":"Onderstepoort J Vet Res"},{"issue":"14","key":"ref70","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.vaccine.2006.05.093","article-title":"Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan","volume":"25","author":"RO Pinheiro","year":"2007","journal-title":"Vaccine"},{"issue":"11","key":"ref71","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.vaccine.2014.01.016","article-title":"Vaccination with <italic>Leishmania mexicana<\/italic> LPG induces PD-1 in CD8(+) and PD-L2 in macrophages thereby suppressing the immune response: a model to assess vaccine efficacy","volume":"32","author":"MB Martinez Salazar","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"ref72","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/505584","article-title":"Synthetic glycovaccine protects against the bite of <italic>Leishmania<\/italic>-infected sand flies","volume":"194","author":"ME Rogers","year":"2006","journal-title":"J Infect Dis"},{"issue":"Pt 2","key":"ref73","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/bj3040603","article-title":"Glycoinositol-phospholipid profiles of four serotypically distinct Old World <italic>Leishmania<\/italic> strains","volume":"304","author":"P Schneider","year":"1994","journal-title":"Biochem J"},{"issue":"2","key":"ref74","doi-asserted-by":"crossref","first-page":"e1543","DOI":"10.1371\/journal.pntd.0001543","article-title":"Glycoinositolphospholipids from <italic>Leishmania braziliensis<\/italic> and <italic>L<\/italic>. <italic>infantum<\/italic>: modulation of innate immune system and variations in carbohydrate structure","volume":"6","author":"RR Assis","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/14760584.2016.1105135","article-title":"<italic>Leishmania<\/italic> vaccine development: exploiting the host-vector-parasite interface","volume":"15","author":"SG Reed","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.meegid.2014.07.028","article-title":"What&apos;s behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity","volume":"28","author":"M Abdeladhim","year":"2014","journal-title":"Infect Genet Evol"},{"issue":"6","key":"ref77","doi-asserted-by":"crossref","first-page":"e1000484","DOI":"10.1371\/journal.ppat.1000484","article-title":"Vector transmission of <italic>Leishmania<\/italic> abrogates vaccine-induced protective immunity","volume":"5","author":"NC Peters","year":"2009","journal-title":"PLoS Pathog"},{"issue":"290","key":"ref78","doi-asserted-by":"crossref","first-page":"290ra90","DOI":"10.1126\/scitranslmed.aaa3043","article-title":"A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates","volume":"7","author":"F Oliveira","year":"2015","journal-title":"Sci Transl Med"},{"issue":"8","key":"ref79","doi-asserted-by":"crossref","first-page":"e1000555","DOI":"10.1371\/journal.ppat.1000555","article-title":"Proteophosophoglycans regurgitated by <italic>Leishmania<\/italic>-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival","volume":"5","author":"M Rogers","year":"2009","journal-title":"PLoS Pathog"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0006039","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T15:18:27Z","timestamp":1693149507000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006039"}},"subtitle":[],"editor":[{"given":"Paulo Filemon","family":"Pimenta","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":79,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006039","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0006039","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]}}}